Collectionner le produit
Détails du produit
Source
Monoclonal Anti-MMAE&MMAF Antibody, Mouse IgG1 is a recombinant mouse monoclonal antibody expressed in HEK293 cells.
Antibody Type
Recombinant Monoclonal
Isotype
Mouse IgG1, Kappa
Immunogen
MMAE
Specificity
Specifically recognizes the target-MMAE&MMAF.
Application
ApplicationRecommended UsageELISA1:4000-1:40000Purification
Protein A purified / Protein G purified.
Concentration
Please refer to the Certificate of Analysis (CoA).
Form
Lyophilized
Formulation
Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.
Please contact us for customized product forms or formulations.
Reconstitution
Please refer to the Certificate of Analysis (CoA) for specific instructions.
Shipping
Lyophilized product is shipped at ambient temperature.
Storage
For long term storage, the product should be stored in a lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 12 months under sterile conditions after reconstitution.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
Les clients ont également consulté
Affichage des données
Bioactivity-ELISA
Immobilized Mouse Anti-MMAE&MMAF Antibody, Mouse IgG1 (Cat. No. MME-M5252) at 5 μg/mL, add Disitamab Vedotin (RC48) in the 50% Mouse serum and then add Biotinylated Human Her2, His,Avitag, premium grade (Cat. No. HE2-H82E2) at 0.5 μg/mL. Detection was performed using HRP-conjugated Streptavidin (Acro, Cat. No. STN-NH913) (QC tested).
Protocol
Immobilized ADC-MMAF at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-MMAE&MMAF Antibody, Mouse IgG1 (Cat. No. MME-M5252) with a linear range of 0.5-1.56 ng/mL (Routinely tested).
Protocol
Immobilized Disitamab Vedotin (RC48) at 0.2 μg/mL (100 μL/well) can bind Monoclonal Anti-MMAE&MMAF Antibody, Mouse IgG1 (Cat. No. MME-M5252) with a linear range of 0.1-2 ng/mL (Routinely tested).
Protocol
Cross Verification
ELISA binding of Monoclonal Anti-MMAE&MMAF Antibody, Mouse IgG1 (Cat. No. MME-M5252) with Trastuzumab Deruxtecan, IgG1-MMAF, Sacituzumab Govitecam, Disitamab Vedotin (RC48), Trastuzumab MMAE and Trastuzumab-DM1 conjugated antibody respectively.
The coating antibody was Monoclonal Anti-MMAE&MMAF Antibody, Mouse IgG1 (Cat. No. MME-M5252), used at 1 μg/mL concentration. The primary antibody were different payload conjugated antibodies, including Trastuzumab Deruxtecan, IgG1-MMAF, Sacituzumab Govitecam, Disitamab Vedotin (RC48), Trastuzumab MMAE and Trastuzumab-DM1 conjugated antibodies used at 0.5 μg/mL concentration. The secondary antibody was Peroxidase AffiniPure Goat Anti-Human IgG, Fcγ fragment specific (min X Bov, Hrs, Ms Sr Prot) (Jackson, Cat. No. 109-035-098) used at 1:12000 concentration.
Monoclonal Anti-MMAE and MMAF Antibody, Mouse IgG1 (Cat. No. MME-M5252) specifically recognizes the MMAE and MMAF payloads. In this assay, it shows binding to ADCs carrying MMAE or MMAF (Disitamab Vedotin (RC48), Trastuzumab MMAE, and a model IgG1-MMAF conjugate), and shows no cross-reactivity with ADCs carrying different payloads (Trastuzumab Deruxtecan (DXd), Sacituzumab Govitecan (SN-38), and Trastuzumab-DM1) under the tested conditions (Routinely tested).
Avis des utilisateurs Publier un commentaire
A***r2022-09-28
J'aimeProduct service was fantastic! The speed of delivery and the availability within Acro is phenomenal! Love the user friendly site and functions to always find what you need when you need it. Working with Acro always is a pleasure, especially when needing to talk to their excellent customer service team! I recommend working with them for all these reasons! Will keep doing business with Acro in the future!
Contact Us
Drug Candidate Licensing
